Practical paediatric psychopharmacological prescribing in autism: The potential and the pitfalls

Autism

Volumn 4, Issue 3, 2000, Pages 229-247

  Gringras, Paul ^a  

^a Harper House Children's Service   (United Kingdom)

Author keywords

Autism; Paediatrics; Psychopharmacology; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; CLOMIPRAMINE; CLONIDINE; FENFLURAMINE; FLUOXETINE; HALOPERIDOL; MELATONIN; METHYLPHENIDATE; NALTREXONE; RISPERIDONE; SECRETIN; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID;

AUTISM; BEHAVIOR DISORDER; HUMAN; PEDIATRICS; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; SOCIAL DISABILITY;

EID: 0033870834     PISSN: 13623613     EISSN: None     Source Type: Journal    
DOI: 10.1177/1362361300004003002     Document Type: Review

References (57)

1. AMAN, M.G., VAN BOURGONDIEN, M.E., WOLFORD, P.L. & SAPHARE, G. (1995) 'Psychotropic and Anticonvulsant Drugs in Subjects with Autism: Prevalence and Patterns of Use', Journal of the American Academy of Child & Adolescent Psychiatry 34: 1672-81.
2. AWAD, G.A. (1996) 'The Use of Selective Serotonin Reuptake Inhibitors in Young Children with Pervasive Developmental Disorders: Some Clinical Observations', Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie 41: 361-6.
3. BUITELAAR, J.K., DEKKER, M.E,. VAN REE, J.M. & VAN ENGLAND, H. (1996) 'A Controlled Trial with ORG 2766, an ACTH-(4-9) Analog, in 50 Relatively Able Children with Autism', European Neuropsychopharmacology 6: 13-19.
4. CAMPBELL, M. (1988) 'Fenfluramine Treatment of Autism', Journal of Child Psychology & Psychiatry 29: 1-10.
5. CAMPBELL, M. (1999) 'Lithium in Hospitalized Aggressive Children with Conduct Disorders: A Double-blind and Placebo-controlled Study', Journal of the American Academy of Child and Adolescent Psychiatry 34(4): 445-53.
6. CAMPBELL, M. ET AL. (1993) 'Naltrexone in Autistic Children: Behavioural Symptoms and Attentional Learning', Journal of the American Academy of Child and Adolescent Psychiatry 32(6): 1283-91.
7. CAMPBELL, M., ANDERSON, L.T., MEIER, M., COHEN, I., SMALL, A.M., et al. (1978) 'A Comparison of Haloperidol and Behaviour Therapy and their Interaction in Autistic Children', Journal of the American Academy of Child & Adolescent Psychiatry 27: 640-55.
8. CAMPBELL, M., SCHOPLER, E., CUEVA, J.E. & HALLIN, A. (1996) 'Treatment of Autistic Disorder', Journal of the American Academy of Child & Adolescent Psychiatry 35: 134-43.
9. CAMPBELL, M., ADAMS, P., PERRY, R. et al. (1998) 'Tardive and Withdrawal Dyskinesia in Autistic Children: A Prospective Study', Psychopharmacology Bulletin 24: 251-5.
10. CHAPPELL, P.B., LECKMAN, J.F., & RIDDLE, M. (1995) 'The Pharmacological Treatment of Tic Disorders', Child and Adolescent Psychiatric Clinics of North America 4: 197-216.
11. CIARANELLO, A.L. & CIARANELLO, R.D. (1995) 'The Neurobiology of Infantile Autism', Annual Review of Neuroscience 18: 101-28.
12. CONNORS, S.L. & CROWELL, D.E. (1999) 'Secretin and Autism: The Role of Cysteine [4]', Journal of the American Academy of Child & Adolescent Psychiatry 38: 795-6.
13. COOK, E.H. & LEVENTHAL, B.L. (1996) 'The Serotonin System in Autism', Current Opinion in Pediatrics 8: 348-84.
14. COOK, E.H., ROWLETT, R., JASELSKIS, C.A. & LEVENTHAL, B.L. (1992) 'Fluoxetine Treatment of Children and Adults with Autistic Disorder and Mental Retardation', Journal of the American Academy of Child & Adolescent Psychiatry 31: 739-45.
15. CRAFT, M., ISMAIL, I.A., KRISHNAUMURTI, D., MATHEWS, J. et al. (1987) 'Lithium in the Treatment of Aggression in Mentally Handicapped Patients: A Double Blind Trial', British Journal of Psychiatry 150: 685-9.
16. DELONG, G.R., TEAGE, L.A. & KARMAN, M.M. (1998) 'Effects of Fluoxetine Treatment in Young Children with Ideopathic Autism', Developmental Medicine & Child Neurology 40: 551-62.
17. DURAND, V.M. & CARR, E.G. (1991) 'Functional Communication Training to Reduce Challenging Behavior: Maintenance and Application in New Settings', Journal of Applied Behavior Analysis 24: 251-64.
18. EVANS, R.W., CLAY, T.H. & GUALTIERI, C.T. (1999) 'Carbamazepine in Pediatric Psychiatry', Journal of the American Academy of Child & Adolescent Psychiatry 26: 2-8.
19. FANKHAUSER, M.P., KARAMANCHI, V.C., GERMAN, M.L. et al. (1992) 'A Double Blind Placebo-Controlled Study of the Efficacy of Transdermal Clonidine in Autism', Journal of Clinical Psychiatry 77-82.
20. FELDMAN, H.M., KOLMEN, B.K., GONZAGA, A.M. & ALDA, M. (1999) 'Naltrexone and Communication Skills in Young Children with Autism', Journal of the American Academy of Child & Adolescent Psychiatry 38: 587-93.
21. FINDLING, R.L., MAXWELL, K., SCOTESE-WOJTILA, L., HUANG, J. & WITNITZER, M. (1997) 'High-Dose Pyridoxine and Magnesium Administration in Children with Autistic Disorder: An Absence of Salutary Effects in a Double-Blind, Placebo Controlled Study', Journal of Autism and Developmental Disorder 27: 467-78.
22. FLAMENT, M.F., RAPOPORT, J.L., BERG, C.B. et al. (1999) 'Clompiramine Treatment of Childhood Obsessive-Compulsive Disorder: A Double-Blind Controlled Study.', Archives of General Psychiatry 42: 977-83.
23. GILLBERG, C. (1995) 'Endogenous Opioids and Opiate Antagonists in Autism: Brief Review of Empirical Findings and Implications for Clinicians', Developmental Medicine & Child Neurology 37: 239-45.
24. GORDON, C.T., STATE, R.C., NELSON, J.E., HAMBURGER, S.D. & RAPOPORT, J.L. (1993) 'A Double-Blind Comparison of Clomipramime, Desipramine, and Placebo in the Treatment of Autistic Disorder', Archives of General Psychiatry 46: 441-7.
25. GRINGRAS, P. & MCNICHOLAS, F. (1999) 'Developing Rational Protocols for Paediatric Psychopharmacological Prescribing', Child: Care, Health and Development 25: 223-33.
26. GUYATT, G.H., SULLIVAN, M.J.J., FALLEN, E. et al. (1990) 'Clinical Usefulness of N of 1 Randomised Control Trials: Three Year Experience', Annals of Internal Medicine 112: 293-9.
27. HORVATH, K., STEFANATOS, G., SOKOLSKI, K.N., WACHTEL, R. et al. (1998) 'Improved Social and Language Skills after Secretin Administration in Patients with Autistic Spectrum Disorders', Journal of the Association for Academic Minority Physicians 9: 9-15.
28. JAN, J.E. (1994) 'The Treatment of Sleep Disorders with Melatonin', Dev. Med. Child Neurology 36(2): 97-107.
29. JASELSKIS, C.A., COOK, E.H., FLETCHER, K.E. & LEVENTHAL, B.L. (1992) 'A Double-Blind, Placebo Controlled Study of the Efficacy of Transdermal Clonidine in Autism', Journal of Clinical Psychopharmacology 12: 77-82.
30. MARSH, J., BIEDERMAN, J. & HOOK, E. (1998) 'Sertraline in Children and Adolescents with OCD', Journal of the American Medical Association 280: 752-6.
31. MARTIN, M., SCAHILL, L., LAWRENCE, M.S.N., KLIN, A.M.I. & VOLKMAR, F.R. (1999) 'Higher-Functioning Pervasive Developmental Disorders: Rates and Patterns of Psychotropic Drug Use', Journal of the American Academy of Child & Adolescent Psychiatry 38: 923-31.
32. MCDOUGLE, C.J. (1997) 'Psychopharmacology', in: D.J. COHEN & F.R. VOLKMAR (eds) Handbook of Autism and Pervasive Developmental Disorders, 2nd edn, pp. 707-29. New York: Wiley.
33. MCDOUGLE, C.J. (1998) 'A Double-blind Placebo-controlled Study of Risperidone in Adults with Autistic Disorders and Other Pervasive Developmental Difficulties', Archives of General Psychiatry 55(7): 633-41.
34. MCDOUGLE, C.J., FLEISCHMANN, R.L., EPPERSON, C.N., WASYLINK, S., LECKMAN, J.F. & PRICE, L.H. (1995) 'Risperidone Addition in Fluvoxamine-Refractory Obsessive-Compulsive Disorder: Three Cases', Journal of Clinical Psychiatry 56: 526-8.
35. MCDOUGLE, C.J., NAYLOR, S.T., COHEN, D.J., VOLKMAR, F.R., HENINGER, G.R. & PRICE, L.H. (1996) 'A Double-Blind, Placebo-Controlled Study of Fluvoxamine in Adults with Autistic Disorder', Archives of General Psychiatry 53: 1001-8.
36. NICOLSON, R., AWAD, G. & SLOMAN, L. (1998) 'An Open Trial of Risperidone in Young Autistic Children', Journal of the American Academy of Child & Adolescent Psychiatry 37: 372-6.
37. PANKSEPP, J. (1980) 'Endogenous Opiods and Social Behaviour', Neurosc. Biobehav. Review 4(4): 473-87.
38. PANKSEPP, J. & LENSING, P. (1991) 'Brief Report: A Synopsis of an Open-Trial of Naltrexone Treatment of Autism with Four Children', Journal of Autism and Developmental Disorders, 21: 243-9.
39. PFEIFFER, S.I., NORTON, J., NELSON, L. & SHOTT, S. (1995) 'Efficacy of Vitamin B6 and Magnesium in the Treatment of Autism: A Methodology Review and Summary of Outcomes', Journal of Autism & Developmental Disorders 25: 480-93.
40. PIAZZA (1999) 'Review of Strategies for Treating Sleep Problems in Persons with Severe or Profound Mental Retardation or Multiple Handicap', American Journal of Mental Retardation 104(2): 170-86.
41. RICHDALE (1999) 'Sleep Problems in Autism: Prevalence, Cause and Intervention', Dev. Med. Child Neurology 41(1): 60-6.
42. RIDDLE, M., KING, R.A. & HARDIN, M. (1991) 'Behavioural Side-Effects with Fluoxetine in Children and Adolescents', Journal of Child & Adolescent Psychopharmacology 4: 31-41.
43. RIMLAND, B. & EDELSON, S.M. (1996) 'Brief Report: Alternative Approaches to the Development of Effective Treatments for Autism', Journal of Autism and Developmental Disorder 25: 237-41.
44. RIVITO, E.R., FREEMAN, B.J., GELLER, E. et al. (1983) 'Effects of Fenfluramine on 14 Outpatients with the Syndrome of Autism', Journal of the American Academy of Child Psychiatry 22: 549-58.
45. SACKETT, D.L., HAYNES, R.B. & TUGWELL, P. (1999) Clinical Epidemiology: A Basic Science for Clinical Medicine, 2nd edn. Boston, MA: Little, Brown.
46. SANDLER, A.D., SUTTON, K.A., DEWEESE, J., GIRARDI, M.A., SHEPPARD, V. & BODFISH, J.W. (1999) 'A Double-Blind, Placebo Controlled Study of Synthetic Human Secretin in the Treatment of Autism and Pervasive Developmental Disorder', New England Journal of Medicine 341: 1801-6.
47. SANTOSH, P.J. & BAIRD, G. (1999) 'Psychopharmacotherapy in Children and Adults with Intellectual Disability', The Lancet 354: 231-40.
48. SCHUSTER, C., LEWIS, M. & SEIDEN, L. (1986) 'Fenfluramine: Neurotoxicity', Psychopharmacology Bulletin 22: 148-51.
49. STEINGARD, R.J., ZIMNITZKY, B., DEMASO, D.R., BAUMAN, M.L. & BUCCI, J.P. (1997) 'Sertraline Treatment of Transition-Associated Anxiety and Agitation in Children with Autistic Disorder', Journal of Child & Adolescent Psychopharmacology 7: 9-15.
50. TSAI, L.Y. (1996) 'Comorbid Psychiatric Disorder of Autistic Disorder', Journal of Autism and Developmental Disorders, 26: 159-63.
51. TSAI, L.Y. (1999) 'Medical Treatment', in D.E. BERKELL ZAGER (ed.) Autism: Identification, Education and Treatment, 2nd edn, pp. 199-257. Mahwah, NJ: Lawrence Erlbaum.
52. TSAI, L.Y. & GHAZIUDDIN, M. (1996) 'Autistic Disorder', in J. WEINER (ed.) The Comprehensive Textbook of Child and Adolescent Psychiatry, 2nd edn, pp. 219-54. Washington, DC: American Psychiatric Press.
53. VOLKMAR, F.R. (1999) 'Lessons from Secretin', New England Journal of Medicine 341: 1842-3.
54. VOLKMAR, F.R., PAUL, R., COHEN, D.J. et al. (1983) 'Irritability in Autistic Children Treated with Fenfluramine', New England Journal of Medicine 309: 187.
55. WACKER, D.P., STEEGE, M.W., NORTHUP, J., SASSO, G., BERG, W., REIMERS, T., COOPER, L., CIGRAND, K. & DONN, L. (1990) 'A Component Analysis of Functional Communication Training Across Three Topographies of Severe Behaviour Problems', Journal of Applied Behaviour Analysis 23: 417-29.
56. WALKUP, J. (1998) 'Fluvoxamine for Childhood OCD: Long-Term Treatment', paper presented at the International Association of Child Psychology and Psychiatry Meeting, Stockholm.
57. ZHDANOVA, I.V., WURTMAN, R.J. & WAGSTAFF, J. (1999) 'Effects of a Low Dose of Melatonin on Sleep in Children with Angelman Syndrome', Journal of Pediatric Endocrinology and Metabolism 12: 57-67.